4-Hydroxy-2-quinolones. 168. Synthesis, chemical and antitubercular properties of 1-R-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides
1-R-4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides have been synthesized as potential antitubercular agents. In contrast to pyrimidin-2-ylamides the compounds prepared are brominated by molecular bromine in glacial acetic acid at position 6 of the quinolone ring rather tha...
Saved in:
Published in | Chemistry of heterocyclic compounds (New York, N.Y. 1965) Vol. 45; no. 9; pp. 1058 - 1068 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Boston
Boston : Springer US
01.09.2009
Springer US Springer Nature |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | 1-R-4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides have been synthesized as potential antitubercular agents. In contrast to pyrimidin-2-ylamides the compounds prepared are brominated by molecular bromine in glacial acetic acid at position 6 of the quinolone ring rather than in the amide part of the molecule. The 1-N-allyl derivative behaves similarly but undergoes halocyclization to give 2-bromomethyl-5-oxo-1,2-dihydro-5H-oxazolo[3,2-a]quinoline-4-carboxylic acid pyrazin-2-ylamide. A comparative analysis of the antimycobacterial properties of the synthesized compounds and their isomeric pyrimidin-2-ylamides has been carried out. |
---|---|
AbstractList | 1-R-4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides have been synthesized as potential antitubercular agents. In contrast to pyrimidin-2-ylamides the compounds prepared are brominated by molecular bromine in glacial acetic acid at position 6 of the quinolone ring rather than in the amide part of the molecule. The 1-N-allyl derivative behaves similarly but undergoes halocyclization to give 2-bromomethyl-5-oxo-1,2-dihydro-5H-oxazolo[3,2-a] quinoline-4-carboxylic acid pyrazin-2-ylamide. A comparative analysis of the antimycobacterial properties of the synthesized compounds and their isomeric pyrimidin-2-ylamides has been carried out. 1-R-4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides have been synthesized as potential antitubercular agents. In contrast to pyrimidin-2-ylamides the compounds prepared are brominated by molecular bromine in glacial acetic acid at position 6 of the quinolone ring rather than in the amide part of the molecule. The 1-N-allyl derivative behaves similarly but undergoes halocyclization to give 2-bromomethyl-5-oxo-1,2-dihydro-5H-oxazolo[3,2- a ]quinoline-4-carboxylic acid pyrazin-2-ylamide. A comparative analysis of the antimycobacterial properties of the synthesized compounds and their isomeric pyrimidin-2-ylamides has been carried out. |
Author | Slobodzian, S. V Ukrainets, I. V Grinevich, L. A Tkach, A. A Bevz, O. V |
Author_xml | – sequence: 1 fullname: Ukrainets, I. V – sequence: 2 fullname: Grinevich, L. A – sequence: 3 fullname: Tkach, A. A – sequence: 4 fullname: Bevz, O. V – sequence: 5 fullname: Slobodzian, S. V |
BookMark | eNqNkEFvFCEYhompidvqD_Akd8vKBzPMzNFs1Jo0MbH2TBj4pkszCyvMxI5_xr9atmN6NB4IAd7nBZ5zchZiQELeAt8C582HDLzuJOO8Y1y2FVMvyAbqRrJW1vKMbPjpRIIQr8h5zvdl2UBbbcifil0tLsWHhQn2c_YhjqU4bymodktvljDtMft8Se0eD96akZrgypj8NPeY7DyaRI8pHjFNHjONAwX2nVVs_9waHyKDS8Gcf9pbL_EBmWTWpL6ERm-psd7R45LMbx8KtIzm4B3m1-TlYMaMb_7OF-T286cfuyt2_e3L193Ha2bLpyaGDTdVB071qlUcQIERg-UVCtf3iKZWXaOM6bltOmiF6KVEizW4zg4OnJMXBNZem2LOCQd9TP5g0qKB65NhvRrWxaM-GdaqMO3K_MI-Dtl6DBafuaJYNFXd8UJzrnZ-MpOPYRfnMBX0_f-jJS3WdC6JcIdJ38c5heLjn697t0KDidrcJZ_17Y3gIDk0AFBL-QgEqavm |
CitedBy_id | crossref_primary_10_1002_chin_201018166 crossref_primary_10_1016_j_bioorg_2019_103291 |
Cites_doi | 10.1016/j.bmcl.2007.11.049 10.1128/AAC.46.4.977-981.2002 10.1021/jm020310n 10.1128/AAC.01494-06 10.1007/s10593-009-0367-7 10.1128/AAC.01369-06 10.1128/AAC.01458-06 10.1002/ardp.200700119 10.1007/s10593-009-0297-4 10.1107/S1600536808013378 10.1128/AAC.00356-07 10.3390/11040242 10.2174/157340607780620635 10.1002/9783527616091 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media, Inc. 2009 |
Copyright_xml | – notice: Springer Science+Business Media, Inc. 2009 |
DBID | FBQ 1KM BLEPL DTL GDOUO AAYXX CITATION |
DOI | 10.1007/s10593-009-0384-6 |
DatabaseName | AGRIS Index Chemicus Web of Science Core Collection Science Citation Index Expanded Web of Science - Science Citation Index Expanded - 2009 CrossRef |
DatabaseTitle | Web of Science CrossRef |
DatabaseTitleList | Web of Science |
Database_xml | – sequence: 1 dbid: 1KM name: Index Chemicus url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC sourceTypes: Enrichment Source Index Database – sequence: 2 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1573-8353 |
EndPage | 1068 |
ExternalDocumentID | 10_1007_s10593_009_0384_6 000274590100006 US201301711153 |
GrantInformation_xml | – fundername: National Institute for Allergic and Infectious Diseases, USA; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID) grantid: 01-AI-45246 |
GroupedDBID | -4Y -58 -5G -BR -EM -Y2 -~C -~X .86 .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 28- 29B 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAGCJ AAHNG AAIAL AAIKT AAJKR AANZL AARHV AARTL AATNV AATVU AAUCO AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDBF ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABJNI ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABPTK ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACHSB ACHXU ACIGE ACIPQ ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACSNA ACTTH ACVWB ACWMK ADHHG ADHIR ADIMF ADINQ ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFEXP AFGCZ AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJGSW AJRNO AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. B0M BA0 BBWZM BDATZ BGNMA CAG COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EAD EAP EBLON EBS EIOEI EJD EMK EPL ESBYG ESX FBQ FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS HF~ HG6 HMJXF HQYDN HRMNR HVGLF HZ~ IAO IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C JBSCW JCJTX JZLTJ KDC KOV KOW LAK LLZTM M4Y MA- N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P9N PF0 PT4 PT5 QOK QOR QOS R4E R89 R9I RHV RNI RNS ROL RPX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3B SAP SCG SCLPG SCM SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SQXTU SRMVM SSLCW STPWE SZN T13 T16 TEORI TSG TSK TSV TUC TUS TWZ U2A UG4 UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 W4F WIP WJK WK8 XU3 YLTOR Z7R Z7U Z7V Z7W Z7X Z7Y Z7Z Z86 Z87 Z8M Z8O Z8P Z8Q Z8S Z8T Z91 ZE2 ZMTXR ~8M ~A9 ~EX ~KM AAPBV 1KM AACDK AAJBT AASML ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU BLEPL DTL GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED AAEOY AAYXX AGJZZ CITATION |
ID | FETCH-LOGICAL-c312t-e70a491d6b68601161a2fc04e2dbbeea56976aab0c791822b33ece51d9cfd1dd3 |
IEDL.DBID | U2A |
ISICitedReferencesCount | 6 |
ISICitedReferencesURI | https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000274590100006 |
ISSN | 0009-3122 |
IngestDate | Thu Sep 12 18:22:39 EDT 2024 Wed Sep 18 00:11:23 EDT 2024 Fri Nov 01 20:04:34 EDT 2024 Sat Dec 16 12:03:28 EST 2023 Wed Dec 27 19:23:11 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | X-ray structural analysis antitubercular activity 1-R-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides 2-aminopyrazine bromination VITRO ANTIMYCOBACTERIAL T-705 IN-VIVO ACTIVITIES DERIVATIVES PYRAZINE |
Language | English |
LinkModel | DirectLink |
LogoURL | https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg |
MergedId | FETCHMERGED-LOGICAL-c312t-e70a491d6b68601161a2fc04e2dbbeea56976aab0c791822b33ece51d9cfd1dd3 |
Notes | http://dx.doi.org/10.1007/s10593-009-0384-6 |
ORCID | 0000-0002-7302-4922 0000-0003-3762-8670 |
PageCount | 11 |
ParticipantIDs | webofscience_primary_000274590100006 fao_agris_US201301711153 crossref_primary_10_1007_s10593_009_0384_6 springer_journals_10_1007_s10593_009_0384_6 webofscience_primary_000274590100006CitationCount |
PublicationCentury | 2000 |
PublicationDate | 2009-09-01 |
PublicationDateYYYYMMDD | 2009-09-01 |
PublicationDate_xml | – month: 09 year: 2009 text: 2009-09-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Boston |
PublicationPlace_xml | – name: Boston – name: NEW YORK |
PublicationTitle | Chemistry of heterocyclic compounds (New York, N.Y. 1965) |
PublicationTitleAbbrev | Chem Heterocycl Comp CHEM HETEROCYCL COM |
PublicationYear | 2009 |
Publisher | Boston : Springer US Springer US Springer Nature |
Publisher_xml | – name: Boston : Springer US – name: Springer US – name: Springer Nature |
References | JampilekJDolezalMBuchtaVMed. Chem.2007327710.2174/1573406077806206351:CAS:528:DC%2BD2sXkvFChur4%3D GobisKFoksHKedziaAWierzchowskaMKwapiszEZwolskaZAugustynowicz-KopećEActa Pol. Pharm.200663391:CAS:528:DC%2BD28XntV2htb0%3D PorterAEAKatritzkyARReesCWComprehensive Heterocyclic Chemistry on CD-ROM: 7-Volume Set1997OxfordElsevier157 InderleidCBNashKALorianVAntibiotics in Laboratory Medicine1996BaltimoreWilliams and Wilkins127 NgoSCZimhonyOChungWJSayahiHJacobsWRWelchJTAntimicrob. Agents Chemother.200751243010.1128/AAC.01458-061:CAS:528:DC%2BD2sXnsVWqu70%3D http://www.taacf.org/ TAACF Assay Results on Publically Available Compounds. BurgiH-BDunitzJDStructure Сorrelation1994VCHWeinheim74110.1002/9783527616091 GowenBBWongMHJungKHSandersABMendenhallMBaileyKWFurutaYSidwellRWAntimicrob. Agents Chemother.200751316810.1128/AAC.00356-071:CAS:528:DC%2BD2sXhtVais7rO UkrainetsI. V.TkachA. A.GrinevichL. A.TurovA. V.BevzO. V.Khim. Geterotsikl. Soedin.200945718 ZefirovYu VKristallografiya1997429361:CAS:528:DyaK2sXnslSnur8%3D UkrainetsI. V.KravtsovaV. V.TkachA. A.RybakovV. B.Khim. Geterotsikl. Soedin.200945875 FurutaYTakahashiKFukudaYKunoMKamiyamaTKozakiKNomuraNEgawaHMinamiSWatanabeYNaritaHShirakiKAntimicrob. Agents Chemother.20024697710.1128/AAC.46.4.977-981.20021:CAS:528:DC%2BD38XisVSjt74%3D El-NaggarAMAbd El-SalamAMAhmedFSLatifMSEl-CadyFAFarmaco [Sci.]1983383911:CAS:528:DyaL3sXlt1aru7Y%3D UkrainetsI. V.MospanovaE. V.SidorenkoL. V.Khim. Geterotsikl. Soedin.2007431023 HeifetsLBHeifetsLBDrug Susceptibility in the Chemotherapy of Mycobacterial Infections1991Boca RatonCRC Press89 LangfordHMWilliamsPDHomnickCFVaccaJPFelockPJStillmockKAWitmerMVHazudaDJGabryelskiLJSchleifWABioorg. Med. Chem. Lett.20081872110.1016/j.bmcl.2007.11.0491:CAS:528:DC%2BD1cXosFWktg%3D%3D SeitzLESulingWJReynoldsRCJ. Med. Chem.200245560410.1021/jm020310n1:CAS:528:DC%2BD38XosVCgur8%3D KleemannAEngelJPharmaceutical Substances. Synthesis, Patents, Applications, Multimedia Viewer, Version 2.002001StuttgartGeorg Thieme Verlag ChohanZHMushtaqSPak. J. Pharm. Sci.200013211:STN:280:DC%2BD28%2Fislymuw%3D%3D DolezalMPalekLVinsovaJBuchtaVJampilekJKralovaKMolecules20061124210.3390/110402421:CAS:528:DC%2BD28Xjs1Shsbo%3D UkrainetsI. V.KolesnikE. V.SidorenkoL. V.GorokhovaO. V.TurovA. V.Khim. Geterotsikl. Soedin.200642874 UkrainetsI. V.SidorenkoL. V.SlobodzianS. V.RybakovV. B.ChernyshevV. V.Khim. Geterotsikl. Soedin.2005411362 G. M. Sheldrick, SHELXTL PLUS. PC Version. A System of Computer Programs for the Determination of Crystal Structure from X-ray Diffraction Data. Rev. 5.1 (1998). UkrainetsI. V.BereznyakovaN. L.DavidenkoA. A.SlobodzianS. V.Khim. Geterotsikl. Soedin.2009451198 ZimhonyOVilchézeCAraiMWelchJTJacobsWRAntimicrob. Agents Chemother.20075175210.1128/AAC.01369-061:CAS:528:DC%2BD2sXhsVyjsL0%3D JulanderJGFurutaYShaferKSidwellRWAntimicrob. Agents Chemother.200751196210.1128/AAC.01494-061:CAS:528:DC%2BD2sXmtlKrsro%3D PalekLDvorákJSvobodováMBuchtaVJampilekJDolezalMArch. Pharm. (Weinheim)20083416110.1002/ardp.2007001191:CAS:528:DC%2BD1cXhsV2rtrg%3D ShishkinaSVShishkinOVUkrainetsIVBereznyakovaNLDavidenkoAAActa Crystallogr.2008E641031 ELNAGGAR, AM (WOS:A1983QW04000004) 1983; 38 HEIFETS LB (WOS:000274590100006.8) 1991 UKRAINETS IV (WOS:000274590100006.20) 2005; 41 Ukrainets, IV (WOS:000269529600009) 2009; 45 Gowen, BB (WOS:000249175400018) 2007; 51 UKRAINETS IV (WOS:000274590100006.23) 2007; 43 Gobis, Katarzyna (MEDLINE:17515328); 63 Zimhony, O (WOS:000243900600050) 2007; 51 Chohan, Z H (MEDLINE:16414835) 2000; 13 BURGI HB (WOS:000274590100006.1) 1994; 2 Julander, JG (WOS:000246991400011) 2007; 51 Ukrainets, IV (WOS:000272158000007) 2009; 45 Jampilek, J (WOS:000253604500008) 2007; 3 Palek, L (WOS:000252649700007) 2008; 341 UKRAINETS IV (WOS:000274590100006.21) 2006; 42 INDERLIED CB (WOS:000274590100006.9) 1996 ZEFIROV YV (WOS:000274590100006.26) 1997; 42 Dolezal, M (WOS:000238940100003) 2006; 11 PORTER AEA (WOS:000274590100006.16) 1984; 3 Ukrainets, IV (WOS:000270826500010) 2009; 45 Shishkina, SV (WOS:000256441200166) 2008; 64 Seitz, LE (WOS:000179632500021) 2002; 45 Ngo, SC (WOS:000247665800020) 2007; 51 Furuta, Y (WOS:000174597000006) 2002; 46 KLEEMANN A (WOS:000274590100006.12) 2001 Langford, HM (WOS:000253410100053) 2008; 18 SHELDRICK GM (WOS:000274590100006.18) 1998 HM Langford (384_CR8) 2008; 18 A Kleemann (384_CR9) 2001 O Zimhony (384_CR15) 2007; 51 384_CR28 L Palek (384_CR14) 2008; 341 K Gobis (384_CR4) 2006; 63 JG Julander (384_CR6) 2007; 51 ZH Chohan (384_CR3) 2000; 13 384_CR24 384_CR23 H-B Burgi (384_CR20) 1994 BB Gowen (384_CR7) 2007; 51 Yu V Zefirov (384_CR21) 1997; 42 SV Shishkina (384_CR25) 2008; E64 LE Seitz (384_CR12) 2002; 45 384_CR1 384_CR18 LB Heifets (384_CR26) 1991 384_CR17 384_CR16 AM El-Naggar (384_CR2) 1983; 38 384_CR22 Y Furuta (384_CR5) 2002; 46 CB Inderleid (384_CR27) 1996 J Jampilek (384_CR10) 2007; 3 AEA Porter (384_CR19) 1997 SC Ngo (384_CR11) 2007; 51 M Dolezal (384_CR13) 2006; 11 |
References_xml | – volume: 43 start-page: 863 year: 2007 ident: WOS:000274590100006.23 publication-title: CHEM HETEROCYCL COMP contributor: fullname: UKRAINETS IV – volume: 18 start-page: 721 year: 2008 ident: WOS:000253410100053 article-title: Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS doi: 10.1016/j.bmcl.2007.11.049 contributor: fullname: Langford, HM – volume: 3 start-page: 277 year: 2007 ident: WOS:000253604500008 article-title: Antimicrobial evaluation of some arylsulfanylpyrazinecarboxylic acid derivatives publication-title: MEDICINAL CHEMISTRY contributor: fullname: Jampilek, J – volume: 2 start-page: 741 year: 1994 ident: WOS:000274590100006.1 publication-title: STRUCTURE CORRELATIO contributor: fullname: BURGI HB – volume: 46 start-page: 977 year: 2002 ident: WOS:000174597000006 article-title: In vitro and in vivo activities of anti-influenza virus compound T-705 publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY doi: 10.1128/AAC.46.4.977-981.2002 contributor: fullname: Furuta, Y – start-page: 127 year: 1996 ident: WOS:000274590100006.9 publication-title: ANTIBIOTICS LAB MED contributor: fullname: INDERLIED CB – volume: 45 start-page: 698 year: 2009 ident: WOS:000270826500010 article-title: 4-HYDROXY-2-QUINOLONES 155. BIOREVERSIBLE CHEMICAL MODIFICATION OF CHINOXYCAINE AT THE TERTIARY AMINO GROUP AS A METHOD OF IMPROVING ITS PHARMACEUTICAL ACTIVITY publication-title: CHEMISTRY OF HETEROCYCLIC COMPOUNDS contributor: fullname: Ukrainets, IV – volume: 45 start-page: 5604 year: 2002 ident: WOS:000179632500021 article-title: Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives publication-title: JOURNAL OF MEDICINAL CHEMISTRY doi: 10.1021/jm020310n contributor: fullname: Seitz, LE – volume: 51 start-page: 1962 year: 2007 ident: WOS:000246991400011 article-title: Activity of T-1106 in a hamster model of yellow fever virus infection publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY doi: 10.1128/AAC.01494-06 contributor: fullname: Julander, JG – volume: 45 start-page: 952 year: 2009 ident: WOS:000272158000007 article-title: 4-Hydroxy-2-quinolones. 167*. Study of the reaction of ethyl 1-alkyl-substituted 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylates with phosphorus oxychloride publication-title: CHEMISTRY OF HETEROCYCLIC COMPOUNDS doi: 10.1007/s10593-009-0367-7 contributor: fullname: Ukrainets, IV – volume: 3 start-page: 157 year: 1984 ident: WOS:000274590100006.16 publication-title: COMPREHENSIVE HETERO contributor: fullname: PORTER AEA – start-page: 89 year: 1991 ident: WOS:000274590100006.8 publication-title: DRUG SUSCEPTIBILITY contributor: fullname: HEIFETS LB – volume: 42 start-page: 936 year: 1997 ident: WOS:000274590100006.26 publication-title: KRISTALLOGRAFIYA contributor: fullname: ZEFIROV YV – year: 1998 ident: WOS:000274590100006.18 publication-title: SHELXTL PLUS PC VERS contributor: fullname: SHELDRICK GM – volume: 11 start-page: 242 year: 2006 ident: WOS:000238940100003 article-title: Substituted pyrazinecarboxamides: Synthesis and biological evaluation publication-title: MOLECULES contributor: fullname: Dolezal, M – volume: 51 start-page: 752 year: 2007 ident: WOS:000243900600050 article-title: Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY doi: 10.1128/AAC.01369-06 contributor: fullname: Zimhony, O – volume: 51 start-page: 2430 year: 2007 ident: WOS:000247665800020 article-title: Inhibition of isolated mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY doi: 10.1128/AAC.01458-06 contributor: fullname: Ngo, SC – volume: 341 start-page: 61 year: 2008 ident: WOS:000252649700007 article-title: Synthesis, antimycobacterial and antifungal evaluation of 3-arylaminopyrazine-2,5-dicarbonitriles publication-title: ARCHIV DER PHARMAZIE doi: 10.1002/ardp.200700119 contributor: fullname: Palek, L – volume: 45 start-page: 567 year: 2009 ident: WOS:000269529600009 article-title: 4-Hydroxy-2-quinolones. 154. Pyrimidin-2-ylamides of 1-R-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acids. Synthesis, structure, and properties publication-title: CHEMISTRY OF HETEROCYCLIC COMPOUNDS doi: 10.1007/s10593-009-0297-4 contributor: fullname: Ukrainets, IV – year: 2001 ident: WOS:000274590100006.12 publication-title: PHARM SUBSTANCES SYN contributor: fullname: KLEEMANN A – volume: 13 start-page: 21 year: 2000 ident: MEDLINE:16414835 article-title: Antibacterial cobalt(II) and zinc(II) complexes of pyrazine-derived NNO and NNN donor Schiff-bases. publication-title: Pakistan journal of pharmaceutical sciences contributor: fullname: Chohan, Z H – volume: 63 start-page: 39 ident: MEDLINE:17515328 article-title: Studies on pyrazine derivatives. XLVII. Synthesis and antibacterial activity of novel pyrazine derivatives with amidoxime moiety. publication-title: Acta poloniae pharmaceutica contributor: fullname: Gobis, Katarzyna – volume: 42 start-page: 765 year: 2006 ident: WOS:000274590100006.21 publication-title: CHEM HETEROCYCL COMP contributor: fullname: UKRAINETS IV – volume: 38 start-page: 391 year: 1983 ident: WOS:A1983QW04000004 article-title: SYNTHESIS AND BIOLOGICAL-ACTIVITY OF SOME NEW 2-(AMINOACYL- AND DIPEPTIDYL-)AMINOPYRAZINE DERIVATIVES publication-title: FARMACO-EDIZIONE SCIENTIFICA contributor: fullname: ELNAGGAR, AM – volume: 64 start-page: O1031 year: 2008 ident: WOS:000256441200166 article-title: 2-bromomethyl-N-isopropyl-7,8-dimethoxy-1,2-dihydro-1,3-oxazolo[3,2-a]quinoline-4-carboxamide publication-title: ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS doi: 10.1107/S1600536808013378 contributor: fullname: Shishkina, SV – volume: 41 start-page: 1158 year: 2005 ident: WOS:000274590100006.20 publication-title: CHEM HETEROCYCL COMP contributor: fullname: UKRAINETS IV – volume: 51 start-page: 3168 year: 2007 ident: WOS:000249175400018 article-title: In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections publication-title: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY doi: 10.1128/AAC.00356-07 contributor: fullname: Gowen, BB – volume: 51 start-page: 1962 year: 2007 ident: 384_CR6 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01494-06 contributor: fullname: JG Julander – ident: 384_CR23 – start-page: 127 volume-title: Antibiotics in Laboratory Medicine year: 1996 ident: 384_CR27 contributor: fullname: CB Inderleid – volume: 45 start-page: 5604 year: 2002 ident: 384_CR12 publication-title: J. Med. Chem. doi: 10.1021/jm020310n contributor: fullname: LE Seitz – volume: 11 start-page: 242 year: 2006 ident: 384_CR13 publication-title: Molecules doi: 10.3390/11040242 contributor: fullname: M Dolezal – volume: 51 start-page: 3168 year: 2007 ident: 384_CR7 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00356-07 contributor: fullname: BB Gowen – volume: 63 start-page: 39 year: 2006 ident: 384_CR4 publication-title: Acta Pol. Pharm. contributor: fullname: K Gobis – volume: 18 start-page: 721 year: 2008 ident: 384_CR8 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2007.11.049 contributor: fullname: HM Langford – ident: 384_CR16 – volume: 341 start-page: 61 year: 2008 ident: 384_CR14 publication-title: Arch. Pharm. (Weinheim) doi: 10.1002/ardp.200700119 contributor: fullname: L Palek – volume: 3 start-page: 277 year: 2007 ident: 384_CR10 publication-title: Med. Chem. doi: 10.2174/157340607780620635 contributor: fullname: J Jampilek – start-page: 157 volume-title: Comprehensive Heterocyclic Chemistry on CD-ROM: 7-Volume Set year: 1997 ident: 384_CR19 contributor: fullname: AEA Porter – start-page: 741 volume-title: Structure Сorrelation year: 1994 ident: 384_CR20 doi: 10.1002/9783527616091 contributor: fullname: H-B Burgi – volume: 51 start-page: 2430 year: 2007 ident: 384_CR11 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01458-06 contributor: fullname: SC Ngo – volume: 13 start-page: 21 year: 2000 ident: 384_CR3 publication-title: Pak. J. Pharm. Sci. contributor: fullname: ZH Chohan – volume-title: Pharmaceutical Substances. Synthesis, Patents, Applications, Multimedia Viewer, Version 2.00 year: 2001 ident: 384_CR9 contributor: fullname: A Kleemann – ident: 384_CR18 – ident: 384_CR28 – ident: 384_CR24 – start-page: 89 volume-title: Drug Susceptibility in the Chemotherapy of Mycobacterial Infections year: 1991 ident: 384_CR26 contributor: fullname: LB Heifets – ident: 384_CR22 – volume: 38 start-page: 391 year: 1983 ident: 384_CR2 publication-title: Farmaco [Sci.] contributor: fullname: AM El-Naggar – volume: 42 start-page: 936 year: 1997 ident: 384_CR21 publication-title: Kristallografiya contributor: fullname: Yu V Zefirov – ident: 384_CR17 – volume: 46 start-page: 977 year: 2002 ident: 384_CR5 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.46.4.977-981.2002 contributor: fullname: Y Furuta – ident: 384_CR1 – volume: 51 start-page: 752 year: 2007 ident: 384_CR15 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01369-06 contributor: fullname: O Zimhony – volume: E64 start-page: 1031 year: 2008 ident: 384_CR25 publication-title: Acta Crystallogr. contributor: fullname: SV Shishkina |
SSID | ssj0007184 |
Score | 1.8519895 |
Snippet | 1-R-4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides have been synthesized as potential antitubercular agents. In contrast to... |
Source | Web of Science |
SourceID | crossref webofscience springer fao |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 1058 |
SubjectTerms | 1-R-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamides 2-aminopyrazine antitubercular activity bromination Chemistry Chemistry and Materials Science Chemistry, Organic Organic Chemistry Pharmacy Physical Sciences Science & Technology X-ray structural analysis |
Title | 4-Hydroxy-2-quinolones. 168. Synthesis, chemical and antitubercular properties of 1-R-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid pyrazin-2-ylamides |
URI | https://link.springer.com/article/10.1007/s10593-009-0384-6 http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000274590100006 |
Volume | 45 |
WOS | 000274590100006 |
WOSCitedRecordID | wos000274590100006 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELb2cYAL4qktj5UPe4KdKnYctzl2y5YKJA4slZZT5CdEoLSkXYn-Gv4qM3mUIq0QHKJIkWM7Hmfm88z4M2NnMUSZhESBVz6CikkGFlEy5GbsrRQObXKTIPtezxfq7XV2fcDkznVRfR32EclGUe_tdcso1Yx8-elYgT5kx4gdFC24FnKy076oa1V_eloqpOwjmbdV8YctOoxmuRcOvdUQNUZndp_d69Ain7TifcAOQvWQ3Zn2h7Q9Yj8VzLeeUlFAwvebkrzkqLyGXOjxkF9tK8R363J9zl1HDMBN5fGiBAEb6iYJla_IIV8TsypfRi7gAyj4sqt1-WMJ4lyCL5tnbSOITSEFZ2qLhb6VjhtXer7a1sRWjS9tcaKVPqwfs8Xs8uN0Dt2ZC-BwtDYQRolRufDa6rGmII0wMrpEBemtDcFkGvGLMTZxoxyXJtKmaXAhEz530Qvv0yfsqMIPPWE8Rlz95DbR0qOpVMpYYaKhcH7qlMvtgL3sR79YtdQaxW8SZRJVgaIqSFSFHrATlE9hPqPqKxZXkgKuYoSKOksH7FUvtKL7Add_q-hsX667llsmH9qJ25jwARP_UmzaEakTgcDm6X915Bm720amKF_tOTva1DfhBQKcjT1lx5OL1xczur_59O7ytJnhvwCwufMX |
link.rule.ids | 315,783,787,27937,27938,41094,41536,42163,42605,52124,52247 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZoOZQL4qkuTx96gk4VO453c6xWVAuUHmhX6s3yEyKh3SXZSuyv4a8yk8eySBWCQy6RYyceZ2bs7_Nnxo5STDKLmYKgQgKVsgIcZslQ2klwUniMyS1B9kLP5urDdXHd7-NuBrb7AEm2nnpns1tBXDNazM8nCvQeu0vy6sTjm8vTrftFZ6uG49NyIeUAZd5WxR_BaC_Z5Q4eemskaqPO2QN2v08X-Wln34fsTlw8YgfT4ZS2x-yngtkmEBcFJHy_qWiZHL3XCRd6csIvNwtM8JqqOea-VwbgdhHwIoaAi3XLQuUrWpGvSVqVLxMX8BkUfN3WuvyxBHEsIVTtva4RTE4hB29rh4W-VZ5bXwW-2tQkV40PbXCkVSE2T9j87N3VdAb9oQvgsbfWEMeZVaUI2umJJpRGWJl8pqIMzsVoC40JjLUu8-MS5ybS5Xn0sRCh9CmIEPKnbH-BH3rIeEo4_SldpmXAWKmUdcImS3h-7pUv3Yi9GXrfrDptDfNbRZlMZdBUhkxl9Igdon2M_YK-z8wvJSGuYoyeushH7O1gNNP_gc3fKjrateu25U7Kh7bitjF8xMS_FJv2SuqkILB-9l8v8podzK4-nZvz9xcfn7N7HUxF5LUXbH9d38SXmO2s3at2dP8CZqrzbA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB7RVAIulKcaWmAPPUE39a7XTnysQkOgqEKUSOVk9gkWyAm2I5H-Gf4qs36EgCoE4uCLZe9zdmZ259tvAA6cdTywgaBGGEeFCyKq0EumiRwZxZlGm1wDZM_i6Uy8uogu2jynZYd270KSzZ0Gz9KUV0cL4442Lr5FHnfmD_bDkaDxFmwLhjuVHmwfv3h_erJWxqh6RZdMLWScd4HNqwr5xTRtOTnfiI5eaZdqGzTZgQ9d6xvoyefBslIDffkbseN_dO823Gr9U3LcCNQduGbzu3Bj3KWFuwffBZ2ujG8B5fTrMvPn8qguB4TFowE5X-XoUZZZeUh0S0VAZG7w8ZAEZYsa9koWPgRQeC5XMneE0bdU0E_rUuff5pQdcmqy-l1TCXrDNKRaFgo_-pJpInVmyGJVeH5s_GmFop0ZW96H2eTk3XhK2ywPVOOEVNQOAykSZmIVj2IfFmKSOx0Iy41S1sooRo9JShXoYYKbIa7C0GobMZNoZ5gx4QPo5djRXSDO4X4rUUHMDRpnIaRi0kkPIAi10Inqw9NugtNFQ-aR_qRt9mOe4pinfszTuA-7KAKp_IjKNp2dcx_iZUM0DVHYh2fdHKbtki__VNDBpuisa264g_zd39pp6AP7m8_GLXW7pyyoHv5TQ57A9TfPJ-nrl2ene3CzCYt5sNw-9KpiaR-hd1Wpx-0K-gG2jhkm |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=4-Hydroxy-2-quinolones.+168.+Synthesis%2C+chemical+and+antitubercular+properties+of+1-R-4-hydroxy-2-oxo-1%2C2-dihydroquinoline-3-carboxylic+acid+pyrazin-2-ylamides&rft.jtitle=Chemistry+of+heterocyclic+compounds+%28New+York%2C+N.Y.+1965%29&rft.au=Ukrainets%2C+I.+V&rft.au=Grinevich%2C+L.+A&rft.au=Tkach%2C+A.+A&rft.au=Bevz%2C+O.+V&rft.date=2009-09-01&rft.pub=Boston+%3A+Springer+US&rft.issn=0009-3122&rft.eissn=1573-8353&rft.volume=45&rft.issue=9&rft.spage=1058&rft.epage=1068&rft_id=info:doi/10.1007%2Fs10593-009-0384-6&rft.externalDocID=US201301711153 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-3122&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-3122&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-3122&client=summon |